Robert N. Fried - Chief Executive Officer, Director at Niagen Bioscience, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Issuer Symbol
NAGE on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Robert N. Fried since 05 Mar 2025

Holdings reported by Robert N. Fried for Niagen Bioscience, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1,038,981 $3,428,637 $3.30 09 Apr 2025 Direct
Common Stock 250,000 $825,000 $3.30 09 Apr 2025 By US Trust Co. of Delaware Trustee of The Benjamin A Fried 2020 Irrevocable Trust dated 02/26/2020
Common Stock 250,000 $825,000 $3.30 09 Apr 2025 By US Trust Co. of Delaware Trustee of The Jeremy W Fried 2020 Irrevocable Trust dated 02/26/2020
Common Stock 95,001 $313,503 $3.30 09 Apr 2025 By Fried-Travis Revocable Trust U/A Dated 06/02/1999
Common Stock 12,746 $42,062 $3.30 09 Apr 2025 Indirect
Performance Stock Unit 1,518,600 25 Feb 2025 Direct Common Stock
Employee Stock Options (right to buy) 503,937 19 Feb 2026 Direct Common Stock
Stock Options (right to buy) 0 09 Apr 2025 Direct Common Stock

Transactions reported by Robert N. Fried for Niagen Bioscience, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.